See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!
My Account 
❘ Contact 
❘ Cart 
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
CBHACayman Chemical Item Number 13172
Histone Deacetylase Inhibitor II; m- 
CBHA (CAS 174664-65-4)
Description
Histone deacetylase (HDAC) inhibitors hyperacetylate histones and increase transcriptional activity in selected genes. Importantly, HDAC inhibitors induce apoptosis in some cancer cells and show promise in the treatment of certain forms of cancer. CBHA is a potent HDAC inhibitor, exhibiting ID50 values of 0.01 and 0.07 μM in vitro for HDAC1 and HDAC3, respectively.1 CBHA also induces apoptosis in nine different neuroblastoma cell lines in culture (0.5-
1 Richon, V.M., Emiliani, S., Verdin, E., et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci USA 95 3003-3007 (1998). 2 Glick, R.D., Swendeman, S.L., Coffey, D.C., et al. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma. Cancer Res 59 4392-4399 (1999 Sep 1).
3
Coffey, D.C., Kutko, M.C., Glick, R.D., et al. The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-
Background ReadingCoffey, D.C., Kutko, M.C., Glick, R.D., et al. The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all- Richon, V.M., Emiliani, S., Verdin, E., et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci USA 95 3003-3007 (1998). Glick, R.D., Swendeman, S.L., Coffey, D.C., et al. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma. Cancer Res 59 4392-4399 (1999 Sep 1). CBHA is available in the following screening libraries: |
This product is available in custom sizes and/or larger quantities. Please contact our Sales Department for a quote or to purchase. Pricing updated 2012-05-26. Prices are subject to change without notice. To ask for assistance with one of our products please contact a Technical Support Scientist. Warning This product is not for human or veterinary use. Related ProductsShow all 16 Hide all but first 3Downloads
Batch-specific InformationLogin to access batch-specific information |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cayman Chemical is a manufacturer, supplier and vendor of biochemical reagents, assay kits, antibodies, and proteins. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2012 Cayman Chemical Company
Quick Search